GVR Report cover Nephrology And Urology Devices Market Size, Share & Trends Report

Nephrology And Urology Devices Market Size, Share & Trends Analysis Report By Product (PCN Catheters, Ureteral Catheters, Urinary Stents, Stone Basket, Urology Guidewires, Renal Dilators), By Region, And Segment Forecasts, 2021 - 2028

  • Report ID: GVR-1-68038-090-3
  • Number of Pages: 120
  • Format: Electronic (PDF)
  • Historical Range: 2016 - 2019
  • Industry: Healthcare

Report Overview

The global nephrology and urology devices market size was valued at USD 4.34 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 6.6% from 2021 to 2028. The high incidence and prevalence of Chronic Kidney Disease (CKD) coupled with rising elderly population is the major factor driving the market growth. According to the estimates of the National Kidney Foundation, 10.0% of the worldwide population is affected by CKD. Thus, the increasing target population is boosting the overall product demand. Rising incidences of diabetes and high blood pressure (hypertension) globally are also contributing to the growth of the market as these two diseases are primary reasons for kidney failure. As per the data published by the American Kidney Fund, 38.4% of kidney failures are caused due to diabetes, and 25% due to high blood pressure.

The U.S. nephrology and urology devices market size, by product, 2016 - 2028 (USD Million)

This high correlation between kidney failure and aforementioned disorders is expected to accentuate the demand for urology & nephrology devices. Moreover, the cases of diabetes and hypertension are increasing in developing countries of Asia Pacific (APAC) & Middle East and North Africa (MENA) regions, owing to changes in lifestyle and rising geriatric population. For instance, as per the International Diabetes Federation, in 2019, the number of diabetes cases in the IDF MENA region was 55 million, which is estimated to reach 108 million by 2045. These factors are expected to increase product use and demand during the forecast period.

In addition, the market is expected to be driven by the increasing geriatric population, which is highly susceptible to various diseases including kidney and urinary disorders. As per the WHO, the number of people aged 65 years and above is expected to rise from 7% in 2000 to 16% in 2050, globally. Old age is considered one of the greatest risk factors for developing various medical conditions. Aging also weakens the immune system and consequently increases a patient’s susceptibility to various ailments, such as renal disorders, diabetes, prostate cancer, and urinary retention. According to the American Society of Nephrology, urologic diseases are the third-most common concern among the geriatric population, and these account for approximately 47% of physician visits.

Furthermore, the growing demand for minimally invasive procedures due to the recent technological innovations is expected to increase product sales. Devices, such as ureteral stents, catheters, guidewires, & renal dilators, are developed using advanced materials including nitinol, polyurethanes/polycarbonates, and silicone. Carbothane is a material resistant to several chemicals, such as iodine, hydrogen peroxide, or alcohol, which increases its life. For instance, MAHURKAR Chronic Carbothane catheter, developed by Medtronic plc is made of Carbothane, which provides superior kink resistance and enables simple single insertion, while facilitating high flow rates with low arterial & vein pressure. Thus, the usage of advanced materials in product manufacturing for enhanced strength and resistance increases the demand, thereby driving the market growth.

Countries, such as U.S. and Canada, have witnessed a high prevalence rate of chronic kidney and urinary disorders owing to sedentary lifestyles. In addition, the increasing number of patients undergoing surgeries and rising consumer awareness about minimally invasive surgeries are also contributing to the market growth in these countries. In addition, as per the Population Reference Bureau fact sheet, the number of people in the U.S. aged 65 years and above is expected to nearly double from 52 million in 2018 to 95 million by 2060 (rise from 16% to 23%). This will support the market growth. Similarly, according to the Canadian Institute for Health Information’s (CIHI) report Canadian Organ Replacement Register (CORR), 2019, the number of people in Manitoba, a Canadian Province, on dialysis has increased by 57% from 2009 to 2019.

Moreover, due to the global pandemic, healthcare facilities, such as hospitals, have been exhausted with a large influx of such patients; therefore, many countries have postponed elective surgeries and other healthcare procedures for an indefinite period. Moreover, the demand for renal disease treatment products used in homecare has increased. Similarly, the demand for home healthcare among the aging population is also increasing as they are at a higher risk of acquiring the infection and cannot visit any healthcare facility. Home health service providers are offering multiple home care services, including the delivery of medicines. This is likely to boost the growth of nephrology and urology devices market during the forecast period.

Product Insights

The others segment held the largest revenue share of 28.49% in 2020 owing to a high prevalence of prostate & colorectal cancer, acute kidney injuries, urolithiasis, and the launch of technologically advanced products by the key players in this segment. For instance, according to the National Health Service (NHS) England, around 61.0% of the male population is suffering from lower urinary tract infections and over 34.0% of women have some type of urinary incontinence. Moreover, the increasing prevalence of the diseases, such as hypertension and diabetes, indicates a higher chance of people suffering from kidney diseases, as both these diseases are the major risk factors for kidney diseases.

The U.K. nephrology and urology devices market share, by product, 2020 (%)

However, the PCN catheters segment is expected to register the fastest CAGR of 7.6% from 2021 to 2028 owing to numerous applications of PCN in urological disorders, such as for the treatment of renal transplants complications, decompression of the perinephric or nephric fluid collection, and nondilated obstructive therapy. Thus, the increasing prevalence of urological diseases, such as cervical cancer, and benefits offered by the PCN catheters are expected to drive the segment growth. For instance, as per the Human Papillomavirus (HPV) Centre fact sheet 2018, in Saudi Arabia, every year, around 316 women are diagnosed with cervical cancer and 158 women die due to the disease. This is expected to boost the segment growth during the forecast period.

Regional Insights

North America dominated the global market with a share of 33.20% in 2020 and will maintain its leading position throughout the forecast period. This growth is attributed to a high prevalence of kidney-associated disorders & supportive government initiatives regarding their treatments, availability of highly skilled physicians, and the presence of well-established healthcare facilities in the region. Furthermore, increasing research funding for the development of advanced devices is positively influencing the market growth in this region. Furthermore, the rising prevalence of diabetes and hypertension is expected to augment the product demand in the region.

However, Asia Pacific is expected to register the fastest CAGR from 2021 to 2028 owing to various factors, such as rising awareness about kidney & urinary disorders, increasing healthcare expenditure levels, and improving healthcare facilities in the region. The increasing prevalence of Benign Prostatic Hyperplasia (BPH), spinal cord injury, and Urinary Tract Infection (UTI) is also driving the regional market. UTI is one of the most prevalent infectious diseases in the region. In addition, the urgent need for the development of new systems and replacing and upgrading the existing medical infrastructure are other factors contributing to the product demand in APAC.

Key Companies & Market Share Insights

Companies are constantly launching new products and increasing their reach through geographical expansion to gain higher market share. For instance, Terumo Corp., a Japanese company, acquired Sequent Medical, a U.S.-based medical device manufacturer, through its subsidiary in the U.S. Thus, the global players are shifting their production facility to other countries to achieve economies of scale.

Moreover, many manufacturers are working in partnership with key medical device distributors to market and supply their products globally or in certain countries. Therefore, strategic alliances are quite common among them. Such alliances not only help the manufactures acquire the license to market their products but also reduces their liability in case of product recall and adverse event. For instance, in February 2019, Coloplast signed a three-year agreement with Premier, Inc., a U.S.-based healthcare improvement company, for its urology products. Some prominent players in the global nephrology and urology devices market include:

  • Medtronic plc

  • Fresenius Medical Care AG & Co. KGaA

  • Baxter International, Inc.

  • Boston Scientific Corp.

  • C.R. Bard, Inc.

  • Cook Group, Inc.

  • Hollister, Inc.

  • Nipro Corp.

  • Terumo Corp.

  • Coloplast A/S

  • ConvaTec Group plc

  • B. Braun AG

  • Teleflex, Inc.

  • Asahi Kasei Corp.

  • Nxstage Medical, Inc.

Nephrology And Urology Devices Market Report Scope

Report Attribute


Market size value in 2021

USD 4.60 billion

Revenue forecast in 2028

USD 7.21 billion

Growth Rate

CAGR of 6.6% from 2021 to 2028

Base year for estimation


Historical data

2016 - 2019

Forecast period

2021 - 2028

Quantitative units

Revenue in USD million/billion and CAGR from 2021 to 2028

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Japan; China; India; South Korea; Australia; Brazil; Mexico; Argentina; Colombia; South Africa; Saudi Arabia; UAE

Key companies profiled

Medtronic plc; Fresenius Medical Care AG & Co. KGaA; Baxter International, Inc.; Boston Scientific Corp.; C.R. Bard, Inc.; Cook Group, Inc.; Hollister, Inc.; Nipro Corp.; Terumo Corp.; Coloplast A/S; ConvaTec Group plc; B. Braun AG; Teleflex, Inc.; Asahi Kasei Corp.; Nxstage Medical, Inc.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global nephrology and urology devices market report on the basis of product and region:

  • Product Outlook (Revenue, USD Million, 2016 - 2028)

    • Ureteral Catheters

    • PCN Catheters

    • Urinary Stents

    • Stone Basket

    • Urology Guidewires

    • Renal Dilators

    • Others

  • Regional Outlook (Revenue, USD Million, 2016 - 2028)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

    • Asia Pacific

      • Japan

      • China

      • India

      • South Korea

      • Australia

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Colombia

    • Middle East and Africa (MEA)

      • South Africa

      • Saudi Arabia

      • UAE

Frequently Asked Questions About This Report




This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.



We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon gvr sidebar D&B icon gvr sidebar

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.